U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 471 - 480 of 972

COVID GUIDANCE: Screening for Suicide Risk during Telehealth Visits

This serves as an addendum to the Action Alliance's 2018 Recommended Standard Care for People with Suicide Risk: Making Health Care Suicide Safe, which report suggested suicide screening, with indicated care as needed, for all individuals receiving care for behavioral health conditions as a core responsibility for health care organizations.
Format
Guide
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
National Action Alliance for Suicide Prevention
Year
Resource Type
PDF
File Size
217 KB

COVID-19 Telehealth Toolkit

This toolkit is curated to help both providers and patients understand more about the benefits of telehealth during the COVID-19 pandemic, as well as understanding the coverage telehealth provides.

Format
Toolkit
Audience
Medical Providers
Organizational Leadership
Other Team Members
Practice Facilitators/Quality Improvement Coaches
Source
National Consortium of Telehealth Resource Centers
Year
Resource Type
PDF
File Size
573 KB

CRAFFT

This revised version of the CRAFFT screening tool incorporates changes that enhance the sensitivity of this well-validated and widely-utilized adolescent substance use screening tool to accurately identify adolescents at risk for a substance use disorder. It also presents new recommended clinician talking points, informed by the latest science and clinician feedback.

Format
Instrument/Protocol
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Source
Car, Relax, Alone, Forget, Friends, Trouble (CRAFFT)
Year
Resource Type
Web Page

Ensuring appropriate quality, access, and utilization of digital therapeutics

This worksheet provides recommendations for patients, clinicians, and payors, on how to ensure digital therapeutic quality, access, and utilization when considering mental health apps, including those for substance use.
Format
Fact Sheet/Brochure
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Source
Digital Therapeutics Alliance (DTA)
Year
Resource Type
PDF
File Size
189 KB

FAQs on Telehealth and HIPAA during the COVID-19 Nationwide Public Health Emergency

A list of frequently asked questions regarding telehealth and HIPAA during the COVID-19 public health emergency.
Format
Other
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Communities
Schools
Policymakers and Payers
States
Source
Office for Civil Rights, U.S. Department of Health and Human Services
Year
Resource Type
PDF
File Size
415 KB

FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency

SAMHSA recognizes the challenges posed by the current COVID-19 situation and is providing the following guidance on the provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency for Opioid Treatment Programs.
Format
Fact Sheet/Brochure
Audience
Medical Providers
Behavioral Health Providers
States
Source
Substance Abuse and Mental Health Services Administration
Year
Resource Type
PDF
File Size
201 KB

Framing Opioid Prescribing Guidelines for Acute Pain

This guideline develops a framework to evaluate existing clinical practice guidelines for prescribing opioids for acute pain indications and recommends indications for which new evidence-based guidelines should be developed.
Format
Guide
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
The National Academies of Sciences, Engineering, and Medicine
Year
Resource Type
PDF
File Size
7.8 MB